nodes	percent_of_prediction	percent_of_DWPC	metapath
Quetiapine—CYP3A7—Delavirdine—acquired immunodeficiency syndrome	0.0224	0.0356	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Delavirdine—acquired immunodeficiency syndrome	0.0224	0.0356	CbGbCtD
Quetiapine—CYP3A7—Indinavir—acquired immunodeficiency syndrome	0.0193	0.0308	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Indinavir—acquired immunodeficiency syndrome	0.0193	0.0308	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Nelfinavir—acquired immunodeficiency syndrome	0.0187	0.0299	CbGbCtD
Quetiapine—CYP3A7—Nelfinavir—acquired immunodeficiency syndrome	0.0187	0.0299	CbGbCtD
Quetiapine—CYP3A5—Nevirapine—acquired immunodeficiency syndrome	0.0186	0.0295	CbGbCtD
Quetiapine—CYP3A7—Saquinavir—acquired immunodeficiency syndrome	0.017	0.027	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Ritonavir—acquired immunodeficiency syndrome	0.017	0.027	CbGbCtD
Quetiapine—CYP3A7-CYP3A51P—Saquinavir—acquired immunodeficiency syndrome	0.017	0.027	CbGbCtD
Quetiapine—CYP3A7—Ritonavir—acquired immunodeficiency syndrome	0.017	0.027	CbGbCtD
Quetiapine—CYP3A5—Delavirdine—acquired immunodeficiency syndrome	0.0168	0.0267	CbGbCtD
Quetiapine—CYP3A5—Amprenavir—acquired immunodeficiency syndrome	0.0168	0.0267	CbGbCtD
Quetiapine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0159	0.0254	CbGbCtD
Quetiapine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.015	0.0238	CbGbCtD
Quetiapine—CYP3A5—Indinavir—acquired immunodeficiency syndrome	0.0145	0.0231	CbGbCtD
Quetiapine—CYP3A5—Nelfinavir—acquired immunodeficiency syndrome	0.0141	0.0224	CbGbCtD
Quetiapine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0135	0.0216	CbGbCtD
Quetiapine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0135	0.0216	CbGbCtD
Quetiapine—CYP3A5—Saquinavir—acquired immunodeficiency syndrome	0.0127	0.0203	CbGbCtD
Quetiapine—CYP3A5—Ritonavir—acquired immunodeficiency syndrome	0.0127	0.0203	CbGbCtD
Quetiapine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0121	0.0193	CbGbCtD
Quetiapine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0121	0.0192	CbGbCtD
Quetiapine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0117	0.0186	CbGbCtD
Quetiapine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0114	0.0181	CbGbCtD
Quetiapine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0114	0.0181	CbGbCtD
Quetiapine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0113	0.0181	CbGbCtD
Quetiapine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0109	0.0174	CbGbCtD
Quetiapine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0103	0.0164	CbGbCtD
Quetiapine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0103	0.0164	CbGbCtD
Quetiapine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0103	0.0163	CbGbCtD
Quetiapine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0103	0.0163	CbGbCtD
Quetiapine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.00983	0.0157	CbGbCtD
Quetiapine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00943	0.015	CbGbCtD
Quetiapine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00915	0.0146	CbGbCtD
Quetiapine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00888	0.0141	CbGbCtD
Quetiapine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00862	0.0137	CbGbCtD
Quetiapine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00828	0.0132	CbGbCtD
Quetiapine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00828	0.0132	CbGbCtD
Quetiapine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00793	0.0126	CbGbCtD
Quetiapine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0078	0.0124	CbGbCtD
Quetiapine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0078	0.0124	CbGbCtD
Quetiapine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00769	0.0123	CbGbCtD
Quetiapine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00723	0.0115	CbGbCtD
Quetiapine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00723	0.0115	CbGbCtD
Quetiapine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00654	0.0104	CbGbCtD
Quetiapine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00654	0.0104	CbGbCtD
Quetiapine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00614	0.00978	CbGbCtD
Quetiapine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00565	0.00899	CbGbCtD
Quetiapine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00548	0.00873	CbGbCtD
Quetiapine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00496	0.0079	CbGbCtD
Quetiapine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00496	0.0079	CbGbCtD
Quetiapine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00475	0.00757	CbGbCtD
Quetiapine—H1F0—semen—acquired immunodeficiency syndrome	0.00379	0.059	CbGeAlD
Quetiapine—DRD1—nerve—acquired immunodeficiency syndrome	0.0018	0.0281	CbGeAlD
Quetiapine—HTR3A—nerve—acquired immunodeficiency syndrome	0.00174	0.0271	CbGeAlD
Quetiapine—HTR7—nerve—acquired immunodeficiency syndrome	0.00113	0.0175	CbGeAlD
Quetiapine—DRD2—nerve—acquired immunodeficiency syndrome	0.00106	0.0166	CbGeAlD
Quetiapine—HTR7—endothelium—acquired immunodeficiency syndrome	0.000959	0.0149	CbGeAlD
Quetiapine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.000891	0.0139	CbGeAlD
Quetiapine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.000852	0.0133	CbGeAlD
Quetiapine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000832	0.0129	CbGeAlD
Quetiapine—CHRM5—skin of body—acquired immunodeficiency syndrome	0.000769	0.012	CbGeAlD
Quetiapine—H1F0—retina—acquired immunodeficiency syndrome	0.000756	0.0118	CbGeAlD
Quetiapine—HTR2A—nerve—acquired immunodeficiency syndrome	0.000702	0.0109	CbGeAlD
Quetiapine—DRD5—lymphoid tissue—acquired immunodeficiency syndrome	0.000694	0.0108	CbGeAlD
Quetiapine—HTR1E—nervous system—acquired immunodeficiency syndrome	0.000694	0.0108	CbGeAlD
Quetiapine—HTR1E—central nervous system—acquired immunodeficiency syndrome	0.000668	0.0104	CbGeAlD
Quetiapine—H1F0—skin of body—acquired immunodeficiency syndrome	0.000663	0.0103	CbGeAlD
Quetiapine—CYP3A5—blood plasma—acquired immunodeficiency syndrome	0.000655	0.0102	CbGeAlD
Quetiapine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000625	0.00973	CbGeAlD
Quetiapine—DRD4—brain—acquired immunodeficiency syndrome	0.000615	0.00958	CbGeAlD
Quetiapine—CHRM4—nervous system—acquired immunodeficiency syndrome	0.000609	0.00948	CbGeAlD
Quetiapine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000598	0.00931	CbGeAlD
Quetiapine—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.000586	0.00913	CbGeAlD
Quetiapine—DRD3—nervous system—acquired immunodeficiency syndrome	0.000566	0.00881	CbGeAlD
Quetiapine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000545	0.00849	CbGeAlD
Quetiapine—HTR6—nervous system—acquired immunodeficiency syndrome	0.000545	0.00848	CbGeAlD
Quetiapine—H1F0—lymphoid tissue—acquired immunodeficiency syndrome	0.000537	0.00837	CbGeAlD
Quetiapine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000531	0.00827	CbGeAlD
Quetiapine—HTR1E—brain—acquired immunodeficiency syndrome	0.000531	0.00826	CbGeAlD
Quetiapine—H1F0—digestive system—acquired immunodeficiency syndrome	0.000531	0.00826	CbGeAlD
Quetiapine—DRD5—nervous system—acquired immunodeficiency syndrome	0.00053	0.00826	CbGeAlD
Quetiapine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000525	0.00817	CbGeAlD
Quetiapine—DRD5—central nervous system—acquired immunodeficiency syndrome	0.000511	0.00795	CbGeAlD
Quetiapine—HTR3A—digestive system—acquired immunodeficiency syndrome	0.000506	0.00788	CbGeAlD
Quetiapine—H1F0—blood—acquired immunodeficiency syndrome	0.000506	0.00787	CbGeAlD
Quetiapine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000492	0.00766	CbGeAlD
Quetiapine—H1F0—bone marrow—acquired immunodeficiency syndrome	0.000489	0.00762	CbGeAlD
Quetiapine—H1F0—spinal cord—acquired immunodeficiency syndrome	0.000487	0.00758	CbGeAlD
Quetiapine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000484	0.00753	CbGeAlD
Quetiapine—HTR3A—blood—acquired immunodeficiency syndrome	0.000482	0.00751	CbGeAlD
Quetiapine—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000476	0.00741	CbGeAlD
Quetiapine—H1F0—vagina—acquired immunodeficiency syndrome	0.000469	0.0073	CbGeAlD
Quetiapine—CHRM4—brain—acquired immunodeficiency syndrome	0.000465	0.00725	CbGeAlD
Quetiapine—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000458	0.00713	CbGeAlD
Quetiapine—H1F0—lung—acquired immunodeficiency syndrome	0.000443	0.0069	CbGeAlD
Quetiapine—DRD2—retina—acquired immunodeficiency syndrome	0.000441	0.00687	CbGeAlD
Quetiapine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000435	0.00677	CbGeAlD
Quetiapine—DRD3—brain—acquired immunodeficiency syndrome	0.000433	0.00674	CbGeAlD
Quetiapine—ADRA1D—nervous system—acquired immunodeficiency syndrome	0.000425	0.00662	CbGeAlD
Quetiapine—HTR3A—lung—acquired immunodeficiency syndrome	0.000423	0.00658	CbGeAlD
Quetiapine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000419	0.00652	CbGeAlD
Quetiapine—HTR6—brain—acquired immunodeficiency syndrome	0.000416	0.00648	CbGeAlD
Quetiapine—H1F0—nervous system—acquired immunodeficiency syndrome	0.00041	0.00639	CbGeAlD
Quetiapine—ADRA1D—central nervous system—acquired immunodeficiency syndrome	0.000409	0.00638	CbGeAlD
Quetiapine—DRD5—brain—acquired immunodeficiency syndrome	0.000405	0.00631	CbGeAlD
Quetiapine—DRD1—nervous system—acquired immunodeficiency syndrome	0.000405	0.00631	CbGeAlD
Quetiapine—H1F0—central nervous system—acquired immunodeficiency syndrome	0.000395	0.00615	CbGeAlD
Quetiapine—HTR3A—nervous system—acquired immunodeficiency syndrome	0.000391	0.0061	CbGeAlD
Quetiapine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.00039	0.00608	CbGeAlD
Quetiapine—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.00039	0.00607	CbGeAlD
Quetiapine—HTR3A—central nervous system—acquired immunodeficiency syndrome	0.000377	0.00587	CbGeAlD
Quetiapine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000374	0.00582	CbGeAlD
Quetiapine—CHRM5—brain—acquired immunodeficiency syndrome	0.000364	0.00566	CbGeAlD
Quetiapine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000348	0.00542	CbGeAlD
Quetiapine—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000344	0.00536	CbGeAlD
Quetiapine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000332	0.00518	CbGeAlD
Quetiapine—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000328	0.00511	CbGeAlD
Quetiapine—HTR7—digestive system—acquired immunodeficiency syndrome	0.000327	0.0051	CbGeAlD
Quetiapine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000327	0.00509	CbGeAlD
Quetiapine—ADRA1D—brain—acquired immunodeficiency syndrome	0.000325	0.00506	CbGeAlD
Quetiapine—CHRM1—lung—acquired immunodeficiency syndrome	0.000321	0.005	CbGeAlD
Quetiapine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.00032	0.00498	CbGeAlD
Quetiapine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.00032	0.00498	CbGeAlD
Quetiapine—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000318	0.00495	CbGeAlD
Quetiapine—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000316	0.00492	CbGeAlD
Quetiapine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000315	0.0049	CbGeAlD
Quetiapine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000315	0.0049	CbGeAlD
Quetiapine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000314	0.0049	CbGeAlD
Quetiapine—H1F0—brain—acquired immunodeficiency syndrome	0.000314	0.00489	CbGeAlD
Quetiapine—HTR7—blood—acquired immunodeficiency syndrome	0.000312	0.00486	CbGeAlD
Quetiapine—DRD1—brain—acquired immunodeficiency syndrome	0.00031	0.00482	CbGeAlD
Quetiapine—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000306	0.00477	CbGeAlD
Quetiapine—CYP2C19—blood—acquired immunodeficiency syndrome	0.000305	0.00474	CbGeAlD
Quetiapine—H1F0—lymph node—acquired immunodeficiency syndrome	0.000303	0.00472	CbGeAlD
Quetiapine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000303	0.00472	CbGeAlD
Quetiapine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000301	0.00469	CbGeAlD
Quetiapine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000301	0.00468	CbGeAlD
Quetiapine—HTR3A—brain—acquired immunodeficiency syndrome	0.000299	0.00466	CbGeAlD
Quetiapine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000297	0.00463	CbGeAlD
Quetiapine—HTR2A—retina—acquired immunodeficiency syndrome	0.000291	0.00453	CbGeAlD
Quetiapine—ADRA2C—blood—acquired immunodeficiency syndrome	0.000287	0.00447	CbGeAlD
Quetiapine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.000286	0.00446	CbGeAlD
Quetiapine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000282	0.0044	CbGeAlD
Quetiapine—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000276	0.0043	CbGeAlD
Quetiapine—HTR7—lung—acquired immunodeficiency syndrome	0.000273	0.00426	CbGeAlD
Quetiapine—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000266	0.00414	CbGeAlD
Quetiapine—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000266	0.00414	CbGeAlD
Quetiapine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000265	0.00413	CbGeAlD
Quetiapine—DRD2—lung—acquired immunodeficiency syndrome	0.000259	0.00403	CbGeAlD
Quetiapine—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.000256	0.00399	CbGeAlD
Quetiapine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000255	0.00397	CbGeAlD
Quetiapine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000253	0.00394	CbGeAlD
Quetiapine—CYP3A5—digestive system—acquired immunodeficiency syndrome	0.000252	0.00392	CbGeAlD
Quetiapine—ADRA2C—lung—acquired immunodeficiency syndrome	0.000251	0.00391	CbGeAlD
Quetiapine—HTR1B—brain—acquired immunodeficiency syndrome	0.000251	0.00391	CbGeAlD
Quetiapine—CHRM2—brain—acquired immunodeficiency syndrome	0.00025	0.00389	CbGeAlD
Quetiapine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000245	0.00381	CbGeAlD
Quetiapine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000244	0.0038	CbGeAlD
Quetiapine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000244	0.0038	CbGeAlD
Quetiapine—HTR1D—brain—acquired immunodeficiency syndrome	0.000243	0.00378	CbGeAlD
Quetiapine—HTR2C—brain—acquired immunodeficiency syndrome	0.000241	0.00375	CbGeAlD
Quetiapine—CYP3A5—blood—acquired immunodeficiency syndrome	0.00024	0.00374	CbGeAlD
Quetiapine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000239	0.00373	CbGeAlD
Quetiapine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000235	0.00366	CbGeAlD
Quetiapine—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.000233	0.00362	CbGeAlD
Quetiapine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000231	0.00359	CbGeAlD
Quetiapine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000229	0.00356	CbGeAlD
Quetiapine—CHRM1—brain—acquired immunodeficiency syndrome	0.000227	0.00354	CbGeAlD
Quetiapine—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.000224	0.00349	CbGeAlD
Quetiapine—CYP3A5—vagina—acquired immunodeficiency syndrome	0.000222	0.00346	CbGeAlD
Quetiapine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.00022	0.00343	CbGeAlD
Quetiapine—HRH1—vagina—acquired immunodeficiency syndrome	0.000216	0.00336	CbGeAlD
Quetiapine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000212	0.0033	CbGeAlD
Quetiapine—CYP3A5—lung—acquired immunodeficiency syndrome	0.00021	0.00328	CbGeAlD
Quetiapine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000204	0.00318	CbGeAlD
Quetiapine—HRH1—lung—acquired immunodeficiency syndrome	0.000204	0.00318	CbGeAlD
Quetiapine—CHRM3—brain—acquired immunodeficiency syndrome	0.000203	0.00317	CbGeAlD
Quetiapine—HTR1A—brain—acquired immunodeficiency syndrome	0.000203	0.00315	CbGeAlD
Quetiapine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000201	0.00312	CbGeAlD
Quetiapine—HTR2A—blood—acquired immunodeficiency syndrome	0.000195	0.00303	CbGeAlD
Quetiapine—HTR7—brain—acquired immunodeficiency syndrome	0.000194	0.00301	CbGeAlD
Quetiapine—ABCB1—retina—acquired immunodeficiency syndrome	0.000191	0.00297	CbGeAlD
Quetiapine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000189	0.00294	CbGeAlD
Quetiapine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000189	0.00294	CbGeAlD
Quetiapine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000187	0.00292	CbGeAlD
Quetiapine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000187	0.00291	CbGeAlD
Quetiapine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000186	0.0029	CbGeAlD
Quetiapine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000186	0.00289	CbGeAlD
Quetiapine—DRD2—brain—acquired immunodeficiency syndrome	0.000183	0.00285	CbGeAlD
Quetiapine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000182	0.00283	CbGeAlD
Quetiapine—HTR2A—vagina—acquired immunodeficiency syndrome	0.00018	0.00281	CbGeAlD
Quetiapine—CYP3A4—blood—acquired immunodeficiency syndrome	0.00018	0.0028	CbGeAlD
Quetiapine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.000179	0.00278	CbGeAlD
Quetiapine—ADRA2C—brain—acquired immunodeficiency syndrome	0.000178	0.00277	CbGeAlD
Quetiapine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000177	0.00276	CbGeAlD
Quetiapine—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000172	0.00268	CbGeAlD
Quetiapine—HTR2A—lung—acquired immunodeficiency syndrome	0.000171	0.00266	CbGeAlD
Quetiapine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000158	0.00246	CbGeAlD
Quetiapine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.000152	0.00237	CbGeAlD
Quetiapine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000146	0.00228	CbGeAlD
Quetiapine—HRH1—brain—acquired immunodeficiency syndrome	0.000145	0.00225	CbGeAlD
Quetiapine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000144	0.00224	CbGeAlD
Quetiapine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000142	0.00221	CbGeAlD
Quetiapine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000141	0.00219	CbGeAlD
Quetiapine—HRH1—lymph node—acquired immunodeficiency syndrome	0.00014	0.00217	CbGeAlD
Quetiapine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000139	0.00216	CbGeAlD
Quetiapine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000137	0.00214	CbGeAlD
Quetiapine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000135	0.00211	CbGeAlD
Quetiapine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000134	0.00208	CbGeAlD
Quetiapine—ABCB1—blood—acquired immunodeficiency syndrome	0.000127	0.00199	CbGeAlD
Quetiapine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000123	0.00192	CbGeAlD
Quetiapine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000123	0.00191	CbGeAlD
Quetiapine—HTR2A—brain—acquired immunodeficiency syndrome	0.000121	0.00188	CbGeAlD
Quetiapine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000118	0.00184	CbGeAlD
Quetiapine—ABCB1—lung—acquired immunodeficiency syndrome	0.000112	0.00174	CbGeAlD
Quetiapine—CYP2D6—brain—acquired immunodeficiency syndrome	0.00011	0.00171	CbGeAlD
Quetiapine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000103	0.00161	CbGeAlD
Quetiapine—ABCB1—central nervous system—acquired immunodeficiency syndrome	9.96e-05	0.00155	CbGeAlD
Quetiapine—Asthenia—Abacavir—acquired immunodeficiency syndrome	7.94e-05	0.00033	CcSEcCtD
Quetiapine—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	7.93e-05	0.00033	CcSEcCtD
Quetiapine—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	7.92e-05	0.000329	CcSEcCtD
Quetiapine—Myalgia—Ritonavir—acquired immunodeficiency syndrome	7.91e-05	0.000329	CcSEcCtD
Quetiapine—Chest pain—Ritonavir—acquired immunodeficiency syndrome	7.91e-05	0.000329	CcSEcCtD
Quetiapine—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	7.91e-05	0.000329	CcSEcCtD
Quetiapine—ABCB1—brain—acquired immunodeficiency syndrome	7.91e-05	0.00123	CbGeAlD
Quetiapine—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	7.89e-05	0.000328	CcSEcCtD
Quetiapine—Anaemia—Lamivudine—acquired immunodeficiency syndrome	7.89e-05	0.000328	CcSEcCtD
Quetiapine—Anxiety—Ritonavir—acquired immunodeficiency syndrome	7.89e-05	0.000328	CcSEcCtD
Quetiapine—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	7.86e-05	0.000327	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	7.86e-05	0.000327	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	7.83e-05	0.000326	CcSEcCtD
Quetiapine—Pruritus—Abacavir—acquired immunodeficiency syndrome	7.82e-05	0.000325	CcSEcCtD
Quetiapine—Fatigue—Indinavir—acquired immunodeficiency syndrome	7.82e-05	0.000325	CcSEcCtD
Quetiapine—Anorexia—Delavirdine—acquired immunodeficiency syndrome	7.82e-05	0.000325	CcSEcCtD
Quetiapine—Discomfort—Ritonavir—acquired immunodeficiency syndrome	7.82e-05	0.000325	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	7.81e-05	0.000325	CcSEcCtD
Quetiapine—Cough—Saquinavir—acquired immunodeficiency syndrome	7.81e-05	0.000324	CcSEcCtD
Quetiapine—Angioedema—Lamivudine—acquired immunodeficiency syndrome	7.8e-05	0.000324	CcSEcCtD
Quetiapine—Pain—Indinavir—acquired immunodeficiency syndrome	7.76e-05	0.000322	CcSEcCtD
Quetiapine—Constipation—Indinavir—acquired immunodeficiency syndrome	7.76e-05	0.000322	CcSEcCtD
Quetiapine—Insomnia—Efavirenz—acquired immunodeficiency syndrome	7.75e-05	0.000322	CcSEcCtD
Quetiapine—Convulsion—Saquinavir—acquired immunodeficiency syndrome	7.75e-05	0.000322	CcSEcCtD
Quetiapine—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	7.74e-05	0.000322	CcSEcCtD
Quetiapine—Hypertension—Saquinavir—acquired immunodeficiency syndrome	7.72e-05	0.000321	CcSEcCtD
Quetiapine—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	7.71e-05	0.000321	CcSEcCtD
Quetiapine—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	7.71e-05	0.000321	CcSEcCtD
Quetiapine—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	7.71e-05	0.00032	CcSEcCtD
Quetiapine—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	7.7e-05	0.00032	CcSEcCtD
Quetiapine—Malaise—Lamivudine—acquired immunodeficiency syndrome	7.7e-05	0.00032	CcSEcCtD
Quetiapine—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	7.68e-05	0.000319	CcSEcCtD
Quetiapine—Nausea—Didanosine—acquired immunodeficiency syndrome	7.68e-05	0.000319	CcSEcCtD
Quetiapine—Vertigo—Lamivudine—acquired immunodeficiency syndrome	7.67e-05	0.000319	CcSEcCtD
Quetiapine—Hypotension—Delavirdine—acquired immunodeficiency syndrome	7.67e-05	0.000319	CcSEcCtD
Quetiapine—Syncope—Lamivudine—acquired immunodeficiency syndrome	7.65e-05	0.000318	CcSEcCtD
Quetiapine—Confusional state—Ritonavir—acquired immunodeficiency syndrome	7.65e-05	0.000318	CcSEcCtD
Quetiapine—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	7.64e-05	0.000318	CcSEcCtD
Quetiapine—ABCB1—lymph node—acquired immunodeficiency syndrome	7.64e-05	0.00119	CbGeAlD
Quetiapine—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	7.64e-05	0.000317	CcSEcCtD
Quetiapine—Somnolence—Efavirenz—acquired immunodeficiency syndrome	7.62e-05	0.000317	CcSEcCtD
Quetiapine—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	7.62e-05	0.000316	CcSEcCtD
Quetiapine—Chest pain—Saquinavir—acquired immunodeficiency syndrome	7.62e-05	0.000316	CcSEcCtD
Quetiapine—Myalgia—Saquinavir—acquired immunodeficiency syndrome	7.62e-05	0.000316	CcSEcCtD
Quetiapine—Anxiety—Saquinavir—acquired immunodeficiency syndrome	7.59e-05	0.000315	CcSEcCtD
Quetiapine—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	7.57e-05	0.000314	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	7.56e-05	0.000314	CcSEcCtD
Quetiapine—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	7.55e-05	0.000314	CcSEcCtD
Quetiapine—Discomfort—Saquinavir—acquired immunodeficiency syndrome	7.53e-05	0.000313	CcSEcCtD
Quetiapine—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	7.5e-05	0.000312	CcSEcCtD
Quetiapine—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	7.48e-05	0.000311	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	7.47e-05	0.000311	CcSEcCtD
Quetiapine—Shock—Ritonavir—acquired immunodeficiency syndrome	7.46e-05	0.00031	CcSEcCtD
Quetiapine—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	7.45e-05	0.00031	CcSEcCtD
Quetiapine—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	7.45e-05	0.00031	CcSEcCtD
Quetiapine—Cough—Lamivudine—acquired immunodeficiency syndrome	7.45e-05	0.000309	CcSEcCtD
Quetiapine—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	7.45e-05	0.000309	CcSEcCtD
Quetiapine—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	7.44e-05	0.000309	CcSEcCtD
Quetiapine—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	7.43e-05	0.000309	CcSEcCtD
Quetiapine—Dizziness—Stavudine—acquired immunodeficiency syndrome	7.42e-05	0.000308	CcSEcCtD
Quetiapine—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	7.42e-05	0.000308	CcSEcCtD
Quetiapine—Insomnia—Delavirdine—acquired immunodeficiency syndrome	7.42e-05	0.000308	CcSEcCtD
Quetiapine—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	7.4e-05	0.000308	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	7.4e-05	0.000308	CcSEcCtD
Quetiapine—Convulsion—Lamivudine—acquired immunodeficiency syndrome	7.4e-05	0.000307	CcSEcCtD
Quetiapine—Vomiting—Nevirapine—acquired immunodeficiency syndrome	7.39e-05	0.000307	CcSEcCtD
Quetiapine—Fatigue—Efavirenz—acquired immunodeficiency syndrome	7.39e-05	0.000307	CcSEcCtD
Quetiapine—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	7.37e-05	0.000306	CcSEcCtD
Quetiapine—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	7.37e-05	0.000306	CcSEcCtD
Quetiapine—Confusional state—Saquinavir—acquired immunodeficiency syndrome	7.36e-05	0.000306	CcSEcCtD
Quetiapine—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	7.33e-05	0.000305	CcSEcCtD
Quetiapine—Olanzapine—ALB—acquired immunodeficiency syndrome	7.33e-05	0.268	CrCbGaD
Quetiapine—Pain—Efavirenz—acquired immunodeficiency syndrome	7.33e-05	0.000305	CcSEcCtD
Quetiapine—Constipation—Efavirenz—acquired immunodeficiency syndrome	7.33e-05	0.000305	CcSEcCtD
Quetiapine—Rash—Nevirapine—acquired immunodeficiency syndrome	7.33e-05	0.000305	CcSEcCtD
Quetiapine—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	7.32e-05	0.000304	CcSEcCtD
Quetiapine—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	7.31e-05	0.000304	CcSEcCtD
Quetiapine—Dizziness—Abacavir—acquired immunodeficiency syndrome	7.31e-05	0.000304	CcSEcCtD
Quetiapine—Somnolence—Delavirdine—acquired immunodeficiency syndrome	7.29e-05	0.000303	CcSEcCtD
Quetiapine—Headache—Nevirapine—acquired immunodeficiency syndrome	7.28e-05	0.000303	CcSEcCtD
Quetiapine—Chest pain—Lamivudine—acquired immunodeficiency syndrome	7.27e-05	0.000302	CcSEcCtD
Quetiapine—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	7.27e-05	0.000302	CcSEcCtD
Quetiapine—Myalgia—Lamivudine—acquired immunodeficiency syndrome	7.27e-05	0.000302	CcSEcCtD
Quetiapine—Infection—Saquinavir—acquired immunodeficiency syndrome	7.25e-05	0.000301	CcSEcCtD
Quetiapine—Anxiety—Lamivudine—acquired immunodeficiency syndrome	7.24e-05	0.000301	CcSEcCtD
Quetiapine—Anorexia—Ritonavir—acquired immunodeficiency syndrome	7.23e-05	0.0003	CcSEcCtD
Quetiapine—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	7.22e-05	0.0003	CcSEcCtD
Quetiapine—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	7.22e-05	0.0003	CcSEcCtD
Quetiapine—Shock—Saquinavir—acquired immunodeficiency syndrome	7.18e-05	0.000298	CcSEcCtD
Quetiapine—Discomfort—Lamivudine—acquired immunodeficiency syndrome	7.18e-05	0.000298	CcSEcCtD
Quetiapine—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	7.17e-05	0.000298	CcSEcCtD
Quetiapine—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	7.17e-05	0.000298	CcSEcCtD
Quetiapine—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	7.16e-05	0.000298	CcSEcCtD
Quetiapine—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	7.16e-05	0.000298	CcSEcCtD
Quetiapine—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	7.15e-05	0.000297	CcSEcCtD
Quetiapine—Vomiting—Stavudine—acquired immunodeficiency syndrome	7.14e-05	0.000297	CcSEcCtD
Quetiapine—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	7.13e-05	0.000296	CcSEcCtD
Quetiapine—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	7.11e-05	0.000295	CcSEcCtD
Quetiapine—Rash—Nelfinavir—acquired immunodeficiency syndrome	7.1e-05	0.000295	CcSEcCtD
Quetiapine—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	7.09e-05	0.000295	CcSEcCtD
Quetiapine—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	7.09e-05	0.000295	CcSEcCtD
Quetiapine—Hypotension—Ritonavir—acquired immunodeficiency syndrome	7.09e-05	0.000295	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	7.08e-05	0.000294	CcSEcCtD
Quetiapine—Rash—Stavudine—acquired immunodeficiency syndrome	7.08e-05	0.000294	CcSEcCtD
Quetiapine—Fatigue—Delavirdine—acquired immunodeficiency syndrome	7.07e-05	0.000294	CcSEcCtD
Quetiapine—Dermatitis—Stavudine—acquired immunodeficiency syndrome	7.07e-05	0.000294	CcSEcCtD
Quetiapine—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	7.07e-05	0.000294	CcSEcCtD
Quetiapine—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	7.06e-05	0.000293	CcSEcCtD
Quetiapine—Headache—Nelfinavir—acquired immunodeficiency syndrome	7.05e-05	0.000293	CcSEcCtD
Quetiapine—Headache—Stavudine—acquired immunodeficiency syndrome	7.03e-05	0.000292	CcSEcCtD
Quetiapine—Vomiting—Abacavir—acquired immunodeficiency syndrome	7.03e-05	0.000292	CcSEcCtD
Quetiapine—Confusional state—Lamivudine—acquired immunodeficiency syndrome	7.02e-05	0.000292	CcSEcCtD
Quetiapine—Pain—Delavirdine—acquired immunodeficiency syndrome	7.02e-05	0.000291	CcSEcCtD
Quetiapine—Constipation—Delavirdine—acquired immunodeficiency syndrome	7.02e-05	0.000291	CcSEcCtD
Quetiapine—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	7.01e-05	0.000291	CcSEcCtD
Quetiapine—Asthenia—Zidovudine—acquired immunodeficiency syndrome	7e-05	0.000291	CcSEcCtD
Quetiapine—Rash—Abacavir—acquired immunodeficiency syndrome	6.97e-05	0.00029	CcSEcCtD
Quetiapine—Dermatitis—Abacavir—acquired immunodeficiency syndrome	6.97e-05	0.000289	CcSEcCtD
Quetiapine—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	6.97e-05	0.000289	CcSEcCtD
Quetiapine—Anorexia—Saquinavir—acquired immunodeficiency syndrome	6.96e-05	0.000289	CcSEcCtD
Quetiapine—Headache—Abacavir—acquired immunodeficiency syndrome	6.93e-05	0.000288	CcSEcCtD
Quetiapine—Infection—Lamivudine—acquired immunodeficiency syndrome	6.92e-05	0.000288	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	6.91e-05	0.000287	CcSEcCtD
Quetiapine—Nausea—Nevirapine—acquired immunodeficiency syndrome	6.91e-05	0.000287	CcSEcCtD
Quetiapine—Pruritus—Zidovudine—acquired immunodeficiency syndrome	6.9e-05	0.000287	CcSEcCtD
Quetiapine—Insomnia—Ritonavir—acquired immunodeficiency syndrome	6.86e-05	0.000285	CcSEcCtD
Quetiapine—Shock—Lamivudine—acquired immunodeficiency syndrome	6.85e-05	0.000285	CcSEcCtD
Quetiapine—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	6.83e-05	0.000284	CcSEcCtD
Quetiapine—Hypotension—Saquinavir—acquired immunodeficiency syndrome	6.82e-05	0.000283	CcSEcCtD
Quetiapine—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	6.82e-05	0.000283	CcSEcCtD
Quetiapine—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	6.81e-05	0.000283	CcSEcCtD
Quetiapine—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	6.78e-05	0.000282	CcSEcCtD
Quetiapine—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	6.78e-05	0.000282	CcSEcCtD
Quetiapine—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	6.77e-05	0.000281	CcSEcCtD
Quetiapine—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	6.76e-05	0.000281	CcSEcCtD
Quetiapine—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	6.76e-05	0.000281	CcSEcCtD
Quetiapine—Thioproperazine—ALB—acquired immunodeficiency syndrome	6.75e-05	0.247	CrCbGaD
Quetiapine—Somnolence—Ritonavir—acquired immunodeficiency syndrome	6.74e-05	0.00028	CcSEcCtD
Quetiapine—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	6.73e-05	0.00028	CcSEcCtD
Quetiapine—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	6.71e-05	0.000279	CcSEcCtD
Quetiapine—Nausea—Nelfinavir—acquired immunodeficiency syndrome	6.69e-05	0.000278	CcSEcCtD
Quetiapine—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	6.69e-05	0.000278	CcSEcCtD
Quetiapine—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	6.68e-05	0.000277	CcSEcCtD
Quetiapine—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	6.68e-05	0.000277	CcSEcCtD
Quetiapine—Nausea—Stavudine—acquired immunodeficiency syndrome	6.67e-05	0.000277	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	6.65e-05	0.000276	CcSEcCtD
Quetiapine—Anorexia—Lamivudine—acquired immunodeficiency syndrome	6.64e-05	0.000276	CcSEcCtD
Quetiapine—Pipotiazine—ALB—acquired immunodeficiency syndrome	6.64e-05	0.243	CrCbGaD
Quetiapine—Thiothixene—ALB—acquired immunodeficiency syndrome	6.64e-05	0.243	CrCbGaD
Quetiapine—Insomnia—Saquinavir—acquired immunodeficiency syndrome	6.6e-05	0.000274	CcSEcCtD
Quetiapine—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	6.59e-05	0.000274	CcSEcCtD
Quetiapine—Nausea—Abacavir—acquired immunodeficiency syndrome	6.57e-05	0.000273	CcSEcCtD
Quetiapine—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	6.56e-05	0.000272	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	6.55e-05	0.000272	CcSEcCtD
Quetiapine—Fatigue—Ritonavir—acquired immunodeficiency syndrome	6.54e-05	0.000272	CcSEcCtD
Quetiapine—Asthenia—Indinavir—acquired immunodeficiency syndrome	6.51e-05	0.000271	CcSEcCtD
Quetiapine—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	6.51e-05	0.00027	CcSEcCtD
Quetiapine—Hypotension—Lamivudine—acquired immunodeficiency syndrome	6.51e-05	0.00027	CcSEcCtD
Quetiapine—Somnolence—Saquinavir—acquired immunodeficiency syndrome	6.49e-05	0.00027	CcSEcCtD
Quetiapine—Pain—Ritonavir—acquired immunodeficiency syndrome	6.49e-05	0.00027	CcSEcCtD
Quetiapine—Constipation—Ritonavir—acquired immunodeficiency syndrome	6.49e-05	0.00027	CcSEcCtD
Quetiapine—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	6.49e-05	0.000269	CcSEcCtD
Quetiapine—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	6.49e-05	0.000269	CcSEcCtD
Quetiapine—Dizziness—Zidovudine—acquired immunodeficiency syndrome	6.45e-05	0.000268	CcSEcCtD
Quetiapine—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	6.43e-05	0.000267	CcSEcCtD
Quetiapine—Pruritus—Indinavir—acquired immunodeficiency syndrome	6.42e-05	0.000267	CcSEcCtD
Quetiapine—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	6.35e-05	0.000264	CcSEcCtD
Quetiapine—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	6.35e-05	0.000264	CcSEcCtD
Quetiapine—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	6.32e-05	0.000262	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	6.3e-05	0.000262	CcSEcCtD
Quetiapine—Insomnia—Lamivudine—acquired immunodeficiency syndrome	6.3e-05	0.000262	CcSEcCtD
Quetiapine—Fatigue—Saquinavir—acquired immunodeficiency syndrome	6.3e-05	0.000262	CcSEcCtD
Quetiapine—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	6.25e-05	0.00026	CcSEcCtD
Quetiapine—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	6.25e-05	0.00026	CcSEcCtD
Quetiapine—Constipation—Saquinavir—acquired immunodeficiency syndrome	6.24e-05	0.000259	CcSEcCtD
Quetiapine—Pain—Saquinavir—acquired immunodeficiency syndrome	6.24e-05	0.000259	CcSEcCtD
Quetiapine—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	6.21e-05	0.000258	CcSEcCtD
Quetiapine—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	6.21e-05	0.000258	CcSEcCtD
Quetiapine—Vomiting—Zidovudine—acquired immunodeficiency syndrome	6.2e-05	0.000258	CcSEcCtD
Quetiapine—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	6.2e-05	0.000258	CcSEcCtD
Quetiapine—Somnolence—Lamivudine—acquired immunodeficiency syndrome	6.19e-05	0.000257	CcSEcCtD
Quetiapine—Rash—Zidovudine—acquired immunodeficiency syndrome	6.15e-05	0.000256	CcSEcCtD
Quetiapine—Asthenia—Efavirenz—acquired immunodeficiency syndrome	6.15e-05	0.000256	CcSEcCtD
Quetiapine—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	6.15e-05	0.000255	CcSEcCtD
Quetiapine—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	6.13e-05	0.000255	CcSEcCtD
Quetiapine—Headache—Zidovudine—acquired immunodeficiency syndrome	6.11e-05	0.000254	CcSEcCtD
Quetiapine—Pruritus—Efavirenz—acquired immunodeficiency syndrome	6.07e-05	0.000252	CcSEcCtD
Quetiapine—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	6.06e-05	0.000252	CcSEcCtD
Quetiapine—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	6.04e-05	0.000251	CcSEcCtD
Quetiapine—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	6.02e-05	0.00025	CcSEcCtD
Quetiapine—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	6.01e-05	0.00025	CcSEcCtD
Quetiapine—Fatigue—Lamivudine—acquired immunodeficiency syndrome	6.01e-05	0.00025	CcSEcCtD
Quetiapine—Dizziness—Indinavir—acquired immunodeficiency syndrome	6e-05	0.000249	CcSEcCtD
Quetiapine—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	6e-05	0.000249	CcSEcCtD
Quetiapine—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	6e-05	0.000249	CcSEcCtD
Quetiapine—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	5.97e-05	0.000248	CcSEcCtD
Quetiapine—Pain—Lamivudine—acquired immunodeficiency syndrome	5.96e-05	0.000248	CcSEcCtD
Quetiapine—Constipation—Lamivudine—acquired immunodeficiency syndrome	5.96e-05	0.000248	CcSEcCtD
Quetiapine—Asthenia—Delavirdine—acquired immunodeficiency syndrome	5.89e-05	0.000245	CcSEcCtD
Quetiapine—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	5.87e-05	0.000244	CcSEcCtD
Quetiapine—Pruritus—Delavirdine—acquired immunodeficiency syndrome	5.8e-05	0.000241	CcSEcCtD
Quetiapine—Nausea—Zidovudine—acquired immunodeficiency syndrome	5.8e-05	0.000241	CcSEcCtD
Quetiapine—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	5.77e-05	0.00024	CcSEcCtD
Quetiapine—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	5.77e-05	0.00024	CcSEcCtD
Quetiapine—Vomiting—Indinavir—acquired immunodeficiency syndrome	5.77e-05	0.00024	CcSEcCtD
Quetiapine—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	5.74e-05	0.000239	CcSEcCtD
Quetiapine—Rash—Indinavir—acquired immunodeficiency syndrome	5.72e-05	0.000238	CcSEcCtD
Quetiapine—Dermatitis—Indinavir—acquired immunodeficiency syndrome	5.72e-05	0.000238	CcSEcCtD
Quetiapine—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	5.7e-05	0.000237	CcSEcCtD
Quetiapine—Headache—Indinavir—acquired immunodeficiency syndrome	5.69e-05	0.000236	CcSEcCtD
Quetiapine—Dizziness—Efavirenz—acquired immunodeficiency syndrome	5.67e-05	0.000236	CcSEcCtD
Quetiapine—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	5.61e-05	0.000233	CcSEcCtD
Quetiapine—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	5.59e-05	0.000232	CcSEcCtD
Quetiapine—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	5.51e-05	0.000229	CcSEcCtD
Quetiapine—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	5.51e-05	0.000229	CcSEcCtD
Quetiapine—Vomiting—Efavirenz—acquired immunodeficiency syndrome	5.45e-05	0.000227	CcSEcCtD
Quetiapine—Asthenia—Ritonavir—acquired immunodeficiency syndrome	5.44e-05	0.000226	CcSEcCtD
Quetiapine—Dizziness—Delavirdine—acquired immunodeficiency syndrome	5.42e-05	0.000225	CcSEcCtD
Quetiapine—Rash—Efavirenz—acquired immunodeficiency syndrome	5.41e-05	0.000225	CcSEcCtD
Quetiapine—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	5.4e-05	0.000224	CcSEcCtD
Quetiapine—Nausea—Indinavir—acquired immunodeficiency syndrome	5.39e-05	0.000224	CcSEcCtD
Quetiapine—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	5.38e-05	0.000224	CcSEcCtD
Quetiapine—Headache—Efavirenz—acquired immunodeficiency syndrome	5.37e-05	0.000223	CcSEcCtD
Quetiapine—Pruritus—Ritonavir—acquired immunodeficiency syndrome	5.37e-05	0.000223	CcSEcCtD
Quetiapine—Asthenia—Saquinavir—acquired immunodeficiency syndrome	5.24e-05	0.000218	CcSEcCtD
Quetiapine—Vomiting—Delavirdine—acquired immunodeficiency syndrome	5.22e-05	0.000217	CcSEcCtD
Quetiapine—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	5.19e-05	0.000216	CcSEcCtD
Quetiapine—Rash—Delavirdine—acquired immunodeficiency syndrome	5.17e-05	0.000215	CcSEcCtD
Quetiapine—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	5.17e-05	0.000215	CcSEcCtD
Quetiapine—Pruritus—Saquinavir—acquired immunodeficiency syndrome	5.17e-05	0.000215	CcSEcCtD
Quetiapine—Headache—Delavirdine—acquired immunodeficiency syndrome	5.14e-05	0.000214	CcSEcCtD
Quetiapine—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	5.13e-05	0.000213	CcSEcCtD
Quetiapine—Nausea—Efavirenz—acquired immunodeficiency syndrome	5.09e-05	0.000212	CcSEcCtD
Quetiapine—Dizziness—Ritonavir—acquired immunodeficiency syndrome	5.02e-05	0.000208	CcSEcCtD
Quetiapine—Asthenia—Lamivudine—acquired immunodeficiency syndrome	5e-05	0.000208	CcSEcCtD
Quetiapine—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	5e-05	0.000208	CcSEcCtD
Quetiapine—Pruritus—Lamivudine—acquired immunodeficiency syndrome	4.93e-05	0.000205	CcSEcCtD
Quetiapine—Nausea—Delavirdine—acquired immunodeficiency syndrome	4.87e-05	0.000202	CcSEcCtD
Quetiapine—Dizziness—Saquinavir—acquired immunodeficiency syndrome	4.83e-05	0.000201	CcSEcCtD
Quetiapine—Vomiting—Ritonavir—acquired immunodeficiency syndrome	4.82e-05	0.0002	CcSEcCtD
Quetiapine—Rash—Ritonavir—acquired immunodeficiency syndrome	4.78e-05	0.000199	CcSEcCtD
Quetiapine—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	4.78e-05	0.000199	CcSEcCtD
Quetiapine—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	4.77e-05	0.000198	CcSEcCtD
Quetiapine—Headache—Ritonavir—acquired immunodeficiency syndrome	4.75e-05	0.000197	CcSEcCtD
Quetiapine—Vomiting—Saquinavir—acquired immunodeficiency syndrome	4.64e-05	0.000193	CcSEcCtD
Quetiapine—Dizziness—Lamivudine—acquired immunodeficiency syndrome	4.61e-05	0.000191	CcSEcCtD
Quetiapine—Rash—Saquinavir—acquired immunodeficiency syndrome	4.6e-05	0.000191	CcSEcCtD
Quetiapine—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	4.6e-05	0.000191	CcSEcCtD
Quetiapine—Headache—Saquinavir—acquired immunodeficiency syndrome	4.57e-05	0.00019	CcSEcCtD
Quetiapine—Nausea—Ritonavir—acquired immunodeficiency syndrome	4.51e-05	0.000187	CcSEcCtD
Quetiapine—Vomiting—Lamivudine—acquired immunodeficiency syndrome	4.43e-05	0.000184	CcSEcCtD
Quetiapine—Rash—Lamivudine—acquired immunodeficiency syndrome	4.39e-05	0.000182	CcSEcCtD
Quetiapine—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	4.39e-05	0.000182	CcSEcCtD
Quetiapine—Headache—Lamivudine—acquired immunodeficiency syndrome	4.36e-05	0.000181	CcSEcCtD
Quetiapine—Nausea—Saquinavir—acquired immunodeficiency syndrome	4.34e-05	0.00018	CcSEcCtD
Quetiapine—Nausea—Lamivudine—acquired immunodeficiency syndrome	4.14e-05	0.000172	CcSEcCtD
Quetiapine—HRH1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.23e-05	0.000184	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.23e-05	0.000184	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.23e-05	0.000184	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.23e-05	0.000184	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.23e-05	0.000184	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.23e-05	0.000184	CbGpPWpGaD
Quetiapine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.23e-05	0.000183	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.23e-05	0.000183	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.22e-05	0.000183	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.22e-05	0.000182	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.22e-05	0.000182	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.22e-05	0.000182	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.22e-05	0.000182	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.22e-05	0.000182	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.21e-05	0.000181	CbGpPWpGaD
Quetiapine—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.2e-05	0.00018	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.2e-05	0.000179	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.2e-05	0.000179	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.2e-05	0.000179	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.19e-05	0.000178	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.18e-05	0.000176	CbGpPWpGaD
Quetiapine—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.18e-05	0.000176	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.18e-05	0.000176	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.18e-05	0.000176	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.18e-05	0.000176	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.16e-05	0.000174	CbGpPWpGaD
Quetiapine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.16e-05	0.000173	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.16e-05	0.000173	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.16e-05	0.000173	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.16e-05	0.000173	CbGpPWpGaD
Quetiapine—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000171	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.14e-05	0.00017	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.13e-05	0.000169	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.13e-05	0.000168	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000168	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.12e-05	0.000168	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.12e-05	0.000167	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.12e-05	0.000167	CbGpPWpGaD
Quetiapine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000167	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.12e-05	0.000167	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.11e-05	0.000166	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.11e-05	0.000166	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.11e-05	0.000166	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.11e-05	0.000166	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.1e-05	0.000165	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.1e-05	0.000164	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.1e-05	0.000164	CbGpPWpGaD
Quetiapine—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.1e-05	0.000164	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.09e-05	0.000163	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.09e-05	0.000163	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.09e-05	0.000163	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.08e-05	0.000161	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.08e-05	0.000161	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.07e-05	0.00016	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.07e-05	0.00016	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.07e-05	0.00016	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.06e-05	0.000159	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.06e-05	0.000159	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.06e-05	0.000159	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.06e-05	0.000158	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000157	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.05e-05	0.000157	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.05e-05	0.000157	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.05e-05	0.000157	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.05e-05	0.000157	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.05e-05	0.000156	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.05e-05	0.000156	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.05e-05	0.000156	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.05e-05	0.000156	CbGpPWpGaD
Quetiapine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000156	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.04e-05	0.000156	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.04e-05	0.000156	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.04e-05	0.000155	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.03e-05	0.000154	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.03e-05	0.000154	CbGpPWpGaD
Quetiapine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000154	CbGpPWpGaD
Quetiapine—ADRA1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000154	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.03e-05	0.000154	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.03e-05	0.000154	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.02e-05	0.000152	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.02e-05	0.000152	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.95e-06	0.000149	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.69e-06	0.000145	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.59e-06	0.000143	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.56e-06	0.000143	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.56e-06	0.000143	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	9.56e-06	0.000143	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	9.56e-06	0.000143	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—IL2—acquired immunodeficiency syndrome	9.53e-06	0.000142	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.48e-06	0.000142	CbGpPWpGaD
Quetiapine—HTR1E—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	9.48e-06	0.000142	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.44e-06	0.000141	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.36e-06	0.00014	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.36e-06	0.00014	CbGpPWpGaD
Quetiapine—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.3e-06	0.000139	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.25e-06	0.000138	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.21e-06	0.000138	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.11e-06	0.000136	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.07e-06	0.000135	CbGpPWpGaD
Quetiapine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.98e-06	0.000134	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.95e-06	0.000134	CbGpPWpGaD
Quetiapine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.93e-06	0.000133	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.88e-06	0.000133	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.82e-06	0.000132	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.81e-06	0.000132	CbGpPWpGaD
Quetiapine—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.69e-06	0.00013	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.68e-06	0.00013	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.64e-06	0.000129	CbGpPWpGaD
Quetiapine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.55e-06	0.000128	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.45e-06	0.000126	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	8.43e-06	0.000126	CbGpPWpGaD
Quetiapine—DRD5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	8.39e-06	0.000125	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.34e-06	0.000125	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.29e-06	0.000124	CbGpPWpGaD
Quetiapine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	8.24e-06	0.000123	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.15e-06	0.000122	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.12e-06	0.000121	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.11e-06	0.000121	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.07e-06	0.000121	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8e-06	0.00012	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.99e-06	0.000119	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.98e-06	0.000119	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.95e-06	0.000119	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.94e-06	0.000119	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.93e-06	0.000118	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.89e-06	0.000118	CbGpPWpGaD
Quetiapine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.88e-06	0.000118	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.87e-06	0.000118	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.86e-06	0.000117	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.85e-06	0.000117	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.83e-06	0.000117	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.83e-06	0.000117	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.81e-06	0.000117	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.76e-06	0.000116	CbGpPWpGaD
Quetiapine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.76e-06	0.000116	CbGpPWpGaD
Quetiapine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.74e-06	0.000116	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.73e-06	0.000116	CbGpPWpGaD
Quetiapine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.71e-06	0.000115	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.71e-06	0.000115	CbGpPWpGaD
Quetiapine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.69e-06	0.000115	CbGpPWpGaD
Quetiapine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.62e-06	0.000114	CbGpPWpGaD
Quetiapine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.59e-06	0.000113	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.32e-06	0.000109	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	7.27e-06	0.000109	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.2e-06	0.000108	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.19e-06	0.000107	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	7.16e-06	0.000107	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.16e-06	0.000107	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.16e-06	0.000107	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.14e-06	0.000107	CbGpPWpGaD
Quetiapine—CYP3A7—Metabolism—ALB—acquired immunodeficiency syndrome	7.08e-06	0.000106	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.07e-06	0.000106	CbGpPWpGaD
Quetiapine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	7.06e-06	0.000105	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.05e-06	0.000105	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.04e-06	0.000105	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.03e-06	0.000105	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.01e-06	0.000105	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.98e-06	0.000104	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.92e-06	0.000103	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.9e-06	0.000103	CbGpPWpGaD
Quetiapine—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	6.87e-06	0.000103	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	6.55e-06	9.79e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.51e-06	9.72e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.5e-06	9.71e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.47e-06	9.67e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.47e-06	9.66e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.46e-06	9.65e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.42e-06	9.6e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	6.41e-06	9.57e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.32e-06	9.45e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.29e-06	9.4e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.22e-06	9.3e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.19e-06	9.25e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.14e-06	9.17e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.11e-06	9.12e-05	CbGpPWpGaD
Quetiapine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	6.08e-06	9.09e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.88e-06	8.78e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.85e-06	8.74e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.6e-06	8.37e-05	CbGpPWpGaD
Quetiapine—HTR1E—Signaling Pathways—IL6—acquired immunodeficiency syndrome	5.6e-06	8.36e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	5.58e-06	8.34e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.57e-06	8.33e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.53e-06	8.26e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.53e-06	8.26e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.5e-06	8.22e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.5e-06	8.22e-05	CbGpPWpGaD
Quetiapine—CYP3A5—Metabolism—ALB—acquired immunodeficiency syndrome	5.12e-06	7.64e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.99e-06	7.45e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.96e-06	7.42e-05	CbGpPWpGaD
Quetiapine—DRD5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.95e-06	7.4e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.82e-06	7.2e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.79e-06	7.16e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.79e-06	7.16e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.77e-06	7.12e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.66e-06	6.96e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.64e-06	6.93e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.59e-06	6.85e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.56e-06	6.82e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.23e-06	6.32e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.21e-06	6.29e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.16e-06	6.22e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.15e-06	6.2e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.14e-06	6.19e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.14e-06	6.18e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.13e-06	6.17e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.13e-06	6.16e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.12e-06	6.15e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.1e-06	6.13e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.09e-06	6.1e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.07e-06	6.09e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.06e-06	6.07e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.05e-06	6.06e-05	CbGpPWpGaD
Quetiapine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	3.96e-06	5.91e-05	CbGpPWpGaD
Quetiapine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	3.86e-06	5.77e-05	CbGpPWpGaD
Quetiapine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.82e-06	5.71e-05	CbGpPWpGaD
Quetiapine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.82e-06	5.71e-05	CbGpPWpGaD
Quetiapine—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.8e-06	5.67e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	3.79e-06	5.66e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	3.77e-06	5.63e-05	CbGpPWpGaD
Quetiapine—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.72e-06	5.55e-05	CbGpPWpGaD
Quetiapine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.66e-06	5.46e-05	CbGpPWpGaD
Quetiapine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	3.64e-06	5.44e-05	CbGpPWpGaD
Quetiapine—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.61e-06	5.39e-05	CbGpPWpGaD
Quetiapine—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.45e-06	5.16e-05	CbGpPWpGaD
Quetiapine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.29e-06	4.92e-05	CbGpPWpGaD
Quetiapine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.25e-06	4.85e-05	CbGpPWpGaD
Quetiapine—ADRA1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.25e-06	4.85e-05	CbGpPWpGaD
Quetiapine—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.93e-06	4.38e-05	CbGpPWpGaD
Quetiapine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.83e-06	4.23e-05	CbGpPWpGaD
Quetiapine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.82e-06	4.21e-05	CbGpPWpGaD
Quetiapine—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.74e-06	4.09e-05	CbGpPWpGaD
Quetiapine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.7e-06	4.03e-05	CbGpPWpGaD
Quetiapine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.49e-06	3.71e-05	CbGpPWpGaD
Quetiapine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.45e-06	3.65e-05	CbGpPWpGaD
Quetiapine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.44e-06	3.65e-05	CbGpPWpGaD
Quetiapine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.43e-06	3.63e-05	CbGpPWpGaD
Quetiapine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.42e-06	3.62e-05	CbGpPWpGaD
Quetiapine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.4e-06	3.59e-05	CbGpPWpGaD
Quetiapine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.39e-06	3.58e-05	CbGpPWpGaD
Quetiapine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.38e-06	3.55e-05	CbGpPWpGaD
Quetiapine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.23e-06	3.32e-05	CbGpPWpGaD
